Microbot Medical (MBOT) News Today $1.60 -0.11 (-6.14%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$1.62 +0.02 (+1.25%) As of 02/21/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Comparing Revolutions Medical (OTCMKTS:RMCP) & Microbot Medical (NASDAQ:MBOT)February 20 at 2:55 AM | americanbankingnews.comMicrobot Medical Announces $13 Million Registered Direct OfferingFebruary 13, 2025 | americanbankingnews.comMicrobot Medical Announces Entry into Material Definitive AgreementFebruary 12, 2025 | americanbankingnews.comMicrobot Medical Inc. Closes $13 Million Registered Direct Offering for Common Stock and Preferred Investment OptionsFebruary 11, 2025 | quiverquant.comMicrobot Medical Closes $13 Million Registered Direct OfferingFebruary 11, 2025 | globenewswire.comMicrobot Medical announces $13M registered direct offering priced at-the-marketFebruary 11, 2025 | markets.businessinsider.comMicrobot Medical Inc. Announces Registered Direct Offering and Concurrent Private Placement Totaling Approximately $13 MillionFebruary 10, 2025 | quiverquant.comMicrobot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesFebruary 10, 2025 | globenewswire.comMicrobot Medical executives receive salary increases and benefitsFebruary 8, 2025 | msn.comMicrobot Medical files to sell 15.97M shares of common stock for holdersFebruary 5, 2025 | markets.businessinsider.comMicrobot Medical® Announces Late-Breaking Abstract Acceptance at the Society of Interventional Radiology Annual MeetingFebruary 4, 2025 | markets.businessinsider.comMicrobot Medical regains Nasdaq compliance with bid priceJanuary 27, 2025 | msn.comMicrobot Medical approves special CEO bonusJanuary 24, 2025 | msn.comMicrobot Medical stock target raised to $9 by H.C. WainwrightJanuary 24, 2025 | msn.comMicrobot Medical price target raised to $9 from $7 at H.C. WainwrightJanuary 24, 2025 | markets.businessinsider.comMicrobot Medical appoints Ahuvia as Director of OperationsJanuary 22, 2025 | markets.businessinsider.comMicrobot Medical® Strengthens Its Management Team in Support of the Anticipated Commercial Launch of LIBERTY®January 21, 2025 | markets.businessinsider.comMicrobot Medical Appoints New Director of OperationsJanuary 21, 2025 | tipranks.comMicrobot Medical Inc. Appoints Michal Ahuvia as Director of Operations to Enhance Production for LIBERTY® LaunchJanuary 21, 2025 | quiverquant.comMicrobot Medical appoints David Wilson to board of directorsJanuary 14, 2025 | markets.businessinsider.comMicrobot Medical® Strengthens Its Commercial Capabilities with the Addition of David J. Wilson to the Board of DirectorsJanuary 13, 2025 | markets.businessinsider.comMicrobot Medical closes $8.6M registered direct offeringJanuary 10, 2025 | markets.businessinsider.comMicrobot Medical Inc. Closes $8.6 Million Registered Direct Offering and Concurrent Private PlacementJanuary 10, 2025 | quiverquant.comMicrobot Medical Closes $8.6 Million Registered Direct OfferingJanuary 10, 2025 | globenewswire.comMicrobot Medical Announces $8.6 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesJanuary 8, 2025 | markets.businessinsider.comMicrobot Medical prices 3.79M shares at $2.27 in registered direct offeringJanuary 8, 2025 | markets.businessinsider.comMicrobot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM FacilityJanuary 7, 2025 | globenewswire.comRise of the machines: Robotics stocks rally amid investor frenzyJanuary 6, 2025 | msn.comMicrobot Medical Announces $7 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesJanuary 6, 2025 | markets.businessinsider.comMicrobot Medical Inc.: Microbot Medical Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTYDecember 30, 2024 | finanznachrichten.deMicrobot Medical anticipates launch of LIBERTY in Q2 in the U.S.December 30, 2024 | markets.businessinsider.comMicrobot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®December 30, 2024 | globenewswire.comMicrobot Medical appoints new director and committee memberDecember 21, 2024 | uk.investing.comMicrobot Medical seeks FDA clearance for endovascular robotic systemDecember 11, 2024 | finance.yahoo.comMicrobot Medical® Announces FDA Submission for the Commercialization of the LIBERTY® Endovascular Robotic SystemDecember 10, 2024 | markets.businessinsider.comMicrobot Medical IncNovember 23, 2024 | money.usnews.comMicrobot Medical Releases Investor Presentation MaterialsNovember 1, 2024 | markets.businessinsider.comMicrobot Medical completes key clinical trial, eyes FDA submissionOctober 17, 2024 | uk.investing.comMicrobot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025October 15, 2024 | globenewswire.comMicrobot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow upSeptember 30, 2024 | globenewswire.comMicrobot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical SystemSeptember 17, 2024 | globenewswire.comMicrobot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic SystemAugust 22, 2024 | globenewswire.comMicrobot Medical Receives Quality Certification to Support Future Regulatory Submissions and CommercializationAugust 13, 2024 | globenewswire.comMicrobot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical SystemAugust 1, 2024 | globenewswire.comMicrobot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer CenterJuly 18, 2024 | globenewswire.comMicrobot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical TrialJuly 9, 2024 | globenewswire.comMicrobot Medical Enrolled the First Patient in its Pivotal Human Clinical TrialJuly 8, 2024 | globenewswire.comMicrobot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical TrialJuly 3, 2024 | globenewswire.comMicrobot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical TrialJune 20, 2024 | globenewswire.comMicrobot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical TrialJune 17, 2024 | globenewswire.com Get Microbot Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter. Email Address MBOT Media Mentions By Week MBOT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MBOT News Sentiment▼0.000.60▲Average Medical News Sentiment MBOT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MBOT Articles This Week▼11▲MBOT Articles Average Week Get Microbot Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Sight Sciences News Jin Medical International News Neuronetics News LENSAR News electroCore News Pro-Dex News Edap Tms News FONAR News TELA Bio News Milestone Scientific News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MBOT) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbot Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Microbot Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.